Literature DB >> 21779448

Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein.

Gelsomina Mansueto1, Floriana Forzati, Angelo Ferraro, Pierlorenzo Pallante, Mimma Bianco, Francesco Esposito, Antonino Iaccarino, Giancarlo Troncone, Alfredo Fusco.   

Abstract

High mobility group A (HMGA) overexpression plays a critical role in neoplastic transformation. To investigate whether HMGA acts by regulating the expression of microRNAs, we analyzed the microRNA expression profile of human breast adenocarcinoma cells (MCF7) transfected with the HMGA1 gene, which results in a highly malignant phenotype. Among the microRNAs induced by HMGA1, we focused on miR-181b, which was overexpressed in several malignant neoplasias including breast carcinomas. We show that miR-181b regulates CBX7 protein levels, which are down-regulated in cancer, and promotes cell cycle progression. We also demonstrate that CBX7, being negatively regulated by HMGA, is able to negatively regulate miR-181b expression. Finally, there was a direct correlation between HMGA1 and miR-181b expression and an inverse correlation between HMGA1 and CBX7 expression in human breast carcinomas. These data indicate the presence of a novel pathway involving HMGA1, miR-181b, and CBX7, which leads to breast cancer progression.

Entities:  

Keywords:  CBX7; HMGA; breast carcinoma; miR-181

Year:  2010        PMID: 21779448      PMCID: PMC3092193          DOI: 10.1177/1947601910366860

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  49 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity.

Authors:  G M Pierantoni; C Rinaldo; F Esposito; M Mottolese; S Soddu; A Fusco
Journal:  Cell Death Differ       Date:  2005-12-09       Impact factor: 15.828

3.  The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element.

Authors:  K Y Chau; U A Patel; K L Lee; H Y Lam; C Crane-Robinson
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

4.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

5.  Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y.

Authors:  K R Johnson; D A Lehn; R Reeves
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

Review 6.  The HMGA proteins: a myriad of functions (Review).

Authors:  Isabelle Cleynen; Wim J M Van de Ven
Journal:  Int J Oncol       Date:  2008-02       Impact factor: 5.650

7.  Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts.

Authors:  M Fedele; M T Berlingieri; S Scala; L Chiariotti; G Viglietto; V Rippel; J Bullerdiek; M Santoro; A Fusco
Journal:  Oncogene       Date:  1998-07-30       Impact factor: 9.867

8.  Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice.

Authors:  Monica Fedele; Vincenzo Fidanza; Sabrina Battista; Francesca Pentimalli; Andres J P Klein-Szanto; Rosa Visone; Ivana De Martino; Antonio Curcio; Carmine Morisco; Luigi Del Vecchio; Gustavo Baldassarre; Claudio Arra; Giuseppe Viglietto; Ciro Indolfi; Carlo M Croce; Alfredo Fusco
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

9.  Thyroid cell transformation requires the expression of the HMGA1 proteins.

Authors:  Maria Teresa Berlingieri; Giovanna M Pierantoni; Vincenzo Giancotti; Massimo Santoro; Alfredo Fusco
Journal:  Oncogene       Date:  2002-05-02       Impact factor: 9.867

10.  Transgenic mice expressing a truncated form of the high mobility group I-C protein develop adiposity and an abnormally high prevalence of lipomas.

Authors:  P Arlotta; A K Tai; G Manfioletti; C Clifford; G Jay; S J Ono
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

View more
  43 in total

Review 1.  Deregulation of microRNA expression in thyroid neoplasias.

Authors:  Pierlorenzo Pallante; Sabrina Battista; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Nat Rev Endocrinol       Date:  2013-11-19       Impact factor: 43.330

Review 2.  Polycomb protein family member CBX7 plays a critical role in cancer progression.

Authors:  Pierlorenzo Pallante; Floriana Forzati; Antonella Federico; Claudio Arra; Alfredo Fusco
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis.

Authors:  Sofía Jerez; Héctor Araya; Daniel Hevia; Carlos E Irarrázaval; Roman Thaler; Andre J van Wijnen; Mario Galindo
Journal:  Gene       Date:  2019-06-06       Impact factor: 3.688

4.  CBX7 is a tumor suppressor in mice and humans.

Authors:  Floriana Forzati; Antonella Federico; Pierlorenzo Pallante; Adele Abbate; Francesco Esposito; Umberto Malapelle; Romina Sepe; Giuseppe Palma; Giancarlo Troncone; Marzia Scarfò; Claudio Arra; Monica Fedele; Alfredo Fusco
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

5.  CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hürthle Cell Adenomas and Carcinomas).

Authors:  Mario Monaco; Gennaro Chiappetta; Concetta Aiello; Antonella Federico; Romina Sepe; Daniela Russo; Alfredo Fusco; Pierlorenzo Pallante
Journal:  Eur Thyroid J       Date:  2014-10-15

Review 6.  Context-dependent actions of Polycomb repressors in cancer.

Authors:  M Koppens; M van Lohuizen
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

7.  Altered microRNA expression in folliculotropic and transformed mycosis fungoides.

Authors:  Dóra Marosvári; Vanda Téglási; Irén Csala; Márta Marschalkó; Csaba Bödör; Botond Timár; Judit Csomor; Judit Hársing; Lilla Reiniger
Journal:  Pathol Oncol Res       Date:  2015-02-20       Impact factor: 3.201

8.  The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Authors:  Paula Mussnich; Daniela D'Angelo; Vincenza Leone; Carlo Maria Croce; Alfredo Fusco
Journal:  Mol Oncol       Date:  2013-01-17       Impact factor: 6.603

9.  miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review).

Authors:  Juan Liu; Weifeng Shi; Changping Wu; Jingfang Ju; Jingting Jiang
Journal:  Biomed Rep       Date:  2013-11-07

10.  Prognosis and Immune Infiltration of Chromobox Family Genes in Sarcoma.

Authors:  Jian Zhou; Ziyuan Chen; Ming Zou; Rongjun Wan; Tong Wu; Yingquan Luo; Gen Wu; Wanchun Wang; Tang Liu
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.